Since January 2026, ANI Pharmaceuticals has been in a holding pattern, posting a small loss of 3.5% while floating around $78.49. The stock also fell short of the S&P 500’s 7.9% gain during that period.
Actualités
Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.
Over the past six months, Wynn Resorts’s shares (currently trading at $95.86) have posted a disappointing 16% loss, well below the S&P 500’s 7.9% gain. This might have investors contemplating their next move.
Since January 2026, Solventum has been in a holding pattern, posting a small loss of 2.2% while floating around $77.29. The stock also fell short of the S&P 500’s 7.9% gain during that period.
Natera has followed the market’s trajectory closely, rising in tandem with the S&P 500 over the past six months. The stock has climbed by 9.1% to $263.44 per share while the index has gained 7.9%.
(Updates with index/price moves and geopolitical news from the first paragraph.) US equity indexe
Dentsply Sirona has been treading water for the past six months, recording a small loss of 0.5% while holding steady at $12.66. The stock also fell short of the S&P 500’s 7.9% gain during that period.
Barrett trades at $39.82 and has moved in lockstep with the market. Its shares have returned 5.5% over the last six months while the S&P 500 has gained 7.9%.
IGSB delivered 3.90% total return last year and offers 4.60% dividend yield through corporate debt. BSV prioritizes stability with broader government exposure and a slightly lower 0.03% expense ratio.
Over the last six months, Planet Labs’s shares have sunk to $22.32, producing a disappointing 13.7% loss - a stark contrast to the S&P 500’s 7.9% gain. This may have investors wondering how to approach the situation.
Tenet and HCA Healthcare present Wall Street with different pictures of their operations as the companies report second-quarter earnings.
PPA delivered $2,411 on a $1,000 five-year investment versus JETS' $1,293, with significantly lower volatility and a 0.74 beta.
Riley Exploration Permian has had an impressive run over the past six months as its shares have beaten the S&P 500 by 23.4%. The stock now trades at $36.04, marking a 31.2% gain. This was partly thanks to its solid quarterly results, and the run-up might have investors contemplating their next move.
Most index funds quietly reward whatever the market already loves, pouring more money into winners just because they won. One ETF is built on the opposite logic, and its recent returns suggest the contrarians might be onto something.
FDVV markets itself as a dividend ETF, but a quarter of its portfolio sits in tech giants that barely yield anything. Whether that tradeoff quietly undermines your income strategy depends on what is actually holding the distribution together.
Wall Street pulled back on Thursday after the S&P 500 had spent recent weeks trading near record territory. The index fell 1.2%, while the Nasdaq dropped 2.15%, as investors digested disappointing earnings from several large tech companies, heavier AI spending plans, higher oil prices, and rising Treasury yields.Claim 55% Off TipRanks Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions Subscribe to TipRanks Smart Investor Newsletter, and dis
(Updates with index/price moves, macroeconomic data and company/geopolitical news from the first par
S&P 500's Forward P/E Falls Below 20x as Market Valuations Cool
While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor execution, weak financials, or structural headwinds.
Digital Realty Trust stock took the top spot on Friday after the data-center real estate investment trust scored an earnings beat and raised its full-year outlook. After Thursday’s market close, the REIT reported adjusted core funds from operations of $2.13 a share, above the $1.87 from a year ago and Wall Street’s expectation of $1.98. Total revenue increased 29% to $1.92 billion; the analyst consensus was $1.66 billion, according to FactSet.
The major indexes bounced back Friday on falling oil prices. Here's what's driving the divergence between old-economy gains and tech-sector jitters.
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Players catalyzing medical advancements have benefited from elevated demand, and their momentum is only rising as the industry has posted a 9.7% gain over the past six months, beating the S&P 500 by 1.8 percentage points.
Whether you see them or not, industrials businesses play a crucial part in our daily activities. Sure, they are at the whim of macroeconomic factors that influence capital spending (like interest rates), but the industry has held its ground over the past six months as its 6.7% return was almost identical to the S&P 500.
While the market treats Salesforce like a sinking ship, one investor keeps loading up on shares and points to a set of receipts that tells a completely different story.
The S&P 500 is hugging the breakeven line, but most of the market is actually on the rise. The market benchmark is down 0.1% after turning higher a few times and losing steam. The Dow is also around breakeven.
Whether you see them or not, industrials businesses play a crucial part in our daily activities. But their prominence also brings high exposure to the ups and downs of economic cycles. Luckily, their overall demand was steady over the past six months as the industry’s 6.7% return has closely followed the S&P 500.
President Trump has proposed new tariffs on roughly 60 countries, adding another layer of uncertainty for investors. On today's Opening Bid panel, featuring Robinhood (HOOD) chief investment officer Stephanie Guild and Miller Tabak managing director and equity strategist Matt Maley, join Executive Editor Brian Sozzi to discuss investment opportunities and portfolio positioning as markets rotate in response to shifting trade policy and broader macroeconomic trends.